MXD: Recorder, Event, Implantable Cardiac, (With Arrhythmia Detection)
What it covers
The arrhythmia detector and alarm device monitors an electrocardiogram and is designed to produce a visible or audible signal or alarm when atrial or ventricular arrhythmia, such as premature contraction or ventricular fibrillation, occurs.
The identification in 21 CFR 870.1025, arrhythmia detector and alarm (including ST-segment measurement and alarm). FDA gives MXD no definition of its own, so the regulation’s describes it.
FDA flags MXD devices as implants.
Recent clearances
| 510(k) | Device | Applicant | Decision | Type |
|---|---|---|---|---|
| K262735 | LINQ II Insertable Cardiac Monitor (ICM) (LNQ22) | Medtronic, Inc. | Aug 28, 2026 | Special |
| K261074 | BIOMONITOR IV (471155) | Biotronik, Inc. | May 1, 2026 | Special |
| K253516 | Assert-IQ (DM5100) | ABBOTT MEDICAL | Dec 18, 2025 | Special |
| K251221 | Assert-IQ (DM5000); Assert-IQ (DM5300); Assert-IQ (DM5500); Merlin.net (MN7000) | Abbott | Sep 17, 2025 | Traditional |
| K252593 | LUX-Dx II Insertable Cardiac Monitor (M302); LUX-Dx II+ Insertable Cardiac Monitor (M312) | Boston Scientific Corporation | Sep 12, 2025 | Special |
| K240693 | LINQ II Insertable Cardiac Monitor (ICM) | Medtronic, Inc. | Mar 28, 2024 | Special |
| K233562 | LINQ II Insertable Cardiac Monitor | Medtronic, Inc. | Dec 6, 2023 | Special |
| K233320 | LINQ II Insertable Cardiac Monitor (LNQ22) | Medtronic, Inc. | Oct 31, 2023 | Special |
| K231328 | LUX-Dx II (M302); LUX-Dx II+ (M312) | Boston Scientific Corp | Aug 19, 2023 | Traditional |
| K230375 | BIOMONITOR IV | Biotronik, Inc. | May 19, 2023 | Traditional |
Clearances by year
34 MXD 510(k)s were cleared from 2011 to Oct 29, 2026. Days to decision run from the day FDA received the 510(k) to its decision, including time on hold.
| Year | Clearances | Median days to decision |
|---|---|---|
| 2026 (so far) | 2 | 29 |
| 2025 | 3 | 36 |
| 2024 | 1 | 15 |
| 2023 | 6 | 76 |
| 2022 | 2 | 41 |
| 2021 | 4 | 57 |
| 2020 | 4 | 127 |
| 2019 | 1 | 122 |
| 2017 | 4 | 52 |
| 2016 | 3 | 63 |
| 2015 | 2 | 124 |
| 2014 | 2 | 216 |
Who submits
6 applicants cleared a MXD device since 2011. 100% of the clearances went to applicants in United States. By type: Traditional 56% and Special 44%.
| Applicant | Clearances since 2011 |
|---|---|
| Medtronic, Inc. | 17 |
| Biotronik, Inc. | 11 |
| Boston Scientific Corporation | 3 |
| Abbott | 1 |
| ABBOTT MEDICAL | 1 |
| Boston Scientific Corp | 1 |
How FDA classifies it
Class II (special controls). The guidance document entitled “Class II Special Controls Guidance Document: Arrhythmia Detector and Alarm” will serve as the special control. See § 870.1 for the availability of this guidance document.
From 21 CFR 870.1025. Special controls are the requirements a 510(k) must show it meets.
Standards
21 CFR 870.1025 names no consensus standards. Check FDA’s recognized standards database, or ask which standards recent MXD clearances declared.
Ask about MXD
Questions about MXD
What is FDA product code MXD?
Product code MXD, “Recorder, Event, Implantable Cardiac, (With Arrhythmia Detection)” in FDA's classification database, is a Class II device type under 21 CFR 870.1025 (arrhythmia detector and alarm (including ST-segment measurement and alarm)), reviewed by FDA's Cardiovascular panel. FDA's 510(k) database lists 34 clearances under MXD, 34 of them since 2011.
How many 510(k) clearances are there under MXD?
FDA’s 510(k) database listed 34 clearances under MXD as of Oct 29, 2026, 34 of them decided since 2011; the most recent decision was Aug 28, 2026. The Predicate Finder searches the live database.
How long does FDA take to clear a MXD 510(k)?
For the 5 MXD clearances decided in the two years before Oct 29, 2026, the median time from FDA receiving the 510(k) to its decision was 30 days. That counts calendar days, including time the submission was on hold waiting for answers from the submitter.
Which companies have the most MXD clearances?
Since 2011: Medtronic, Inc. (17), Biotronik, Inc. (11), Boston Scientific Corporation (3), Abbott (1) and ABBOTT MEDICAL (1). 6 applicants have cleared a MXD device in that time.